Curis reports narrowed Q2 loss, advances emavusertib studies

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/18/2026

1. NVDA
2. DOO
3. ARGX
4. HD
5. FN
6. METC
7. SPY
8. WEAV
9. TSLA
10. INFQ

Go back to Curis reports narrowed Q2 loss, advances emavusertib studies
Curis, Inc. (NASDAQ: CRIS) Delayed: 1.76 -0.04 (2.22%)
Previous Close $1.80    52 Week High $3.70 
Open $1.83    52 Week Low $1.25 
Day High $1.93    P/E N/A 
Day Low $1.71    EPS $-0.15 
Volume 147,720